From: <Salvato da Windows Internet Explorer 7>
Subject: In search of virus HIV
Date: Sun, 30 Mar 2008 20:48:05 +0200
MIME-Version: 1.0
Content-Type: multipart/related;
	type="text/html";
	boundary="----=_NextPart_000_00A0_01C892A7.5AA1DC50"
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2900.3198

This is a multi-part message in MIME format.

------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: text/html;
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
Content-Location: http://www.cesil.com/0898/enfrah08.htm

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML><HEAD><TITLE>In search of virus HIV</TITLE>
<META http-equiv=3DContent-Type content=3D"text/html; =
charset=3Diso-8859-1">
<META content=3D"Fabio Franchi" name=3DAuthor>
<META content=3D"MSHTML 6.00.5730.13" name=3DGENERATOR>
<META content=3Dmedicine name=3DClassification>
<META content=3D"hiv, virus hiv, test virus hiv," name=3DKeyWords>
<META=20
content=3D"In search of virus HIV: analysis of the value of the tests =
used of HIV infection"=20
name=3DDescription></HEAD>
<BODY text=3D#000000 vLink=3D#993300 aLink=3D#ffff00 link=3D#cc0000 =
bgColor=3D#ffffff><IMG=20
height=3D109=20
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_33dd44b.mht!htt=
p://www.cesil.com/0898/migltin1.gif"=20
width=3D120 align=3DABSCENTER><FONT =
color=3D#ffffff>.........</FONT>&nbsp;<IMG=20
height=3D20=20
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/tosctin2.gif"=20
width=3D550 align=3DABSCENTER>=20
<CENTER>
<TABLE cellSpacing=3D0 cols=3D1 cellPadding=3D0 width=3D600 border=3D0>
  <TBODY>
  <TR>
    <TD vAlign=3Dcenter align=3Dmiddle>
      <DIV align=3Dright><IMG height=3D39=20
      =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/frahtes1.jpg"=20
      width=3D151 align=3DABSCENTER></DIV></TD></TR>
  <TR>
    <TD><IMG height=3D141=20
      src=3D"http://83.224.70.4/www.cesil.comm/0898/frahte2e.jpg"=20
  width=3D600></TD></TR></TBODY></TABLE></CENTER>
<CENTER>&nbsp;<B><I><FONT face=3DArial,Helvetica><FONT =
color=3D#000000><FONT=20
size=3D-1>Fabio Franchi</FONT></FONT></FONT></I></B></CENTER>
<CENTER>
<TABLE cellSpacing=3D0 cols=3D1 cellPadding=3D0 width=3D600=20
background=3Dhttp://www.cesil.com/0898/ficasfon.jpg border=3D0>
  <TBODY>
  <TR>
    <TD>
      <CENTER><FONT face=3DArial,Helvetica><FONT color=3D#ffffff><FONT=20
      size=3D-1>Abstract&nbsp;<A=20
      href=3D"http://www.cesil.com/0898/eafrah08.htm"><IMG height=3D15=20
      =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/ficapalb.jpg"=20
      width=3D15 align=3DABSCENTER=20
      border=3D0></A>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
Curriculum&nbsp;<A=20
      href=3D"http://www.cesil.com/0898/cufrah08.htm"><IMG height=3D15=20
      =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/ficapalb.jpg"=20
      width=3D15 align=3DABSCENTER=20
      border=3D0></A>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=20
      Bibliografia&nbsp;<A =
href=3D"http://www.cesil.com/0898/bifrah08.htm"><IMG=20
      height=3D15=20
      =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/ficapalb.jpg"=20
      width=3D15 align=3DABSCENTER=20
    =
border=3D0></A></FONT></FONT></FONT>&nbsp;</CENTER></TD></TR></TBODY></TA=
BLE></CENTER>&nbsp;<A=20
href=3D"http://www.cesil.com/0898/itfrah08.htm"><IMG height=3D27=20
src=3D"http://83.224.70.4/www.cesil.comm/0898/ita.gif" width=3D54 =
border=3D0></A>=20
<CENTER>
<TABLE cellSpacing=3D0 cols=3D2 cellPadding=3D7 width=3D750 border=3D0>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop align=3Dleft><B><I><FONT =
face=3DArial,Helvetica><FONT=20
      color=3D#3333ff><FONT size=3D-1>=93The task of researchers is to =
try to falsify=20
      as many theories as =
possible=94&nbsp;</FONT></FONT></FONT></I></B>&nbsp;=20
      <DIV align=3Dright><B><I><FONT face=3DArial,Helvetica><FONT =
size=3D-1><FONT=20
      color=3D#000000>Karl Popper</FONT><FONT=20
      =
color=3D#3333ff>&nbsp;</FONT></FONT></FONT></I></B></DIV><B><I><FONT=20
      face=3DArial,Helvetica><FONT color=3D#3333ff><FONT size=3D-1>=93Is =
there a danger,=20
      in molecular biology, that the accumulation of data will get so =
far ahead=20
      of its assimilation into a conceptual framework that the data will =

      eventually prove an encumbrance? Part of the trouble is that =
excitement of=20
      the chase leaves little time for reflection. And there are grants =
for=20
      producing data, but hardly any for standing back in=20
      contemplation=94.</FONT></FONT></FONT></I></B>&nbsp;=20
      <DIV align=3Dright><B><I><FONT face=3DArial,Helvetica><FONT=20
      color=3D#000000><FONT size=3D-1>John Maddox=20
      (1)</FONT></FONT></FONT></I></B></DIV>&nbsp;<FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>According to the AIDS =
infectious=20
      theory, the HIV infection is active since from the first phases =
and during=20
      the years and it is very difficult for the organism to get rid of =
it.=20
      Proper tests reveal its presence. Those which at the moment are at =
our=20
      disposal are essential not only for the diagnosis (2), but they =
are used=20
      as indicative elements with prognostic and therapeutical purposes=20
      (3).&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>As science for definition is open to every control and =
all its=20
      demonstrations must be proved on the basis of logical rules, this =
study=20
      has the object of verifying if there is effective relation among =
the=20
      different =93AIDS tests=94 and the meaning attributed to them. We =
shall=20
      examine the most important: the tests of the antibodies (the =
ELISA, the=20
      Western Blot and the p24), the viral culture, the genetic =
identification=20
      with amplification methods, the viral isolation, the micrographs =
of HIV.=20
      We shall analyse and criticize the procedure followed at present, =
as=20
      presented in the updated specialized texts including =93AIDS, =
Biology,=20
      Diagnosis, Treatment and Prevention=94 (2) published in 1997, =
edited by=20
      several top researchers including A. Fauci, former manager of the =
National=20
      Institute of Health.&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>In other words we tried to =
answer to=20
      the crucial question as the great clinician and science =
methodology=20
      scholar, prof. Augusto Murri would have formulated it: =93Why have =
I to=20
      believe that the AIDS test meaning is equivalent to an infection =
with the=20
      HIV virus?=94 He thought it was essential, during one's life, to =
be in the=20
      habit of criticizing before of accepting =
information.</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>ANALYSIS OF THE =
ANTIBODY=20
      TESTS</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>The tests of the =
antibodies we=20
      shall examine are the Elisa, the Western Blot, the p24 antigen =
capture=20
      assay.</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>ELISA (Pict.=20
      1)</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>In Italy, the =
screening test=20
      (ELISA), =93provided with a good sensibility (near 99%) and a =
lower=20
      specificity, valued about 90-95% in 1988=94(4), is used at first =
to identify=20
      the HIV infection. However these percentages must not deceive, in =
fact the=20
      test predictive value changes depending on the infection =
prevalence in a=20
      certain population. According to a theory expressed in 1988 by the =
AIDS=20
      National Commission (4), in case of screening of the Italian =
prison=20
      population, in comparison with 6,902 real positive individuals =
there=20
      should have been 1.751 false positive; on the contrary, in case of =
blood=20
      donors, in comparison with 198 real positive, a good 999,990 =
should have=20
      been false positive (505 times more!). In the over mentioned text =
(2) the=20
      authors assert that the progressive improvements took sensibility =
of the=20
      test to 95% and its specificity to 99.8%, in high-risk population. =

      Nevertheless they admit that =93the positive predictive value can =
greatly=20
      fluctuate depending on the population they study=94. Actually this =
happened.=20
      Depending on the information published on the English =
authoritative=20
      medical magazine The Lancet (5), in 1990 on 20.2 million ELISA =
tests made=20
      in Russia, 20,000 were positive, but only 112 were confirmed by =
the WB; in=20
      1991, on 30 million ELISA tests, a good 30,000 were positive, but =
of these=20
      only 66 were confirmed by the Western Blot, that is a minimum =
percentage=20
      (0.002%).</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>=93Then as the ELISA test has been planned to optimize =
the=20
      sensibility to the detriment of the specificity, it should not be =
used by=20
      itself for the HIV-1 infection diagnosis without a confirmation =
test (2),=20
      although in some Countries is used alone.</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>Western Blot =
(pict.=20
      2)</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>The Western Blot =
is commonly=20
      used as a confirmation test of HIV infection; the combination of =
the Elisa=20
      and the WB should have a =93positive predictive value higher than =
99% for=20
      low-risk and high-risk population=94 (2).</FONT></FONT>&nbsp; =
<BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>However even the WB does =
not seem to be=20
      so specific as sustained if we analyze some data at our=20
      disposal.&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>A) Even official sources acknowledge that =93for =
reasonable=20
      disagreements it was very difficult to code the definition on what =
a=20
      positive Western Blot should be considered=94 (2) . Since 1993, in =
United=20
      States there were just 5 official criteria, and only one =
(indicated in Du=20
      Pont's diagnostic kit) was approved by FDA (Food and Drug =
Administration).=20
      This was the most restrictive one and was used by a few =
laboratories. If=20
      only this criterion had been used , in United States only the 50%=20
      seropositive individuals would have been confirmed as really =
infected (6)!=20
      In Italy in a publication of the Health Ministry directed towards =
G.P.=20
      (7), the authors denied there had ever been such a problem. On =
this=20
      subject they affirmed: =93in most cases, quite apart from the =
criterion=20
      used, the test results correctly coded when the individual is=20
      infect=94.&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>The remedy to such a situation was found simply =
standardizing the=20
      different criteria without reconsidering the past and without =
explaining=20
      the scientific reasons for which they opted in that=20
      way.&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>Afterwards the CDC identified their criteria with the =
ASTPHLD's=20
      ones and in 1993 the United States Red Cross conformed adopting =
the=20
      ASTPHLD/CDC's advice=94(2). =93According to the American authority =
ASTPHLD, a=20
      positive result must present at least two of the three main bands =
of=20
      diagnostic meaning (antigp-41, anti-gp120/160,=20
      anti-p24)=94.</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>B)The reading of the WB is visual and therefore is =
liable to=20
      interpretation from the operator, a variability factor not =
negligible.=20
      =93Its technique (note: the Western Blot) was not standardized, =
the=20
      importance and the consequences occurred in the laboratories have =
not been=20
      yet measured.&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>Their results must be =
interpreted; the=20
      criteria for these interpretations vary not only from laboratory =
to=20
      laboratory, but even from month to month..=94 (8). The Consortium =
for=20
      Retroviral Serology Standardization (CRSS) made a quality control=20
      study*and sent 19 aliquots of the same serum to 19 different USA =
reference=20
      laboratories. Results comparison has shown an incredible =
differences of=20
      the number of bands and of their intensity (6) (pict.=20
      3).</FONT></FONT>&nbsp; <BR><FONT face=3DArial,Helvetica><FONT =
size=3D-1>C)=20
      The antigenic preparations are not purified.</FONT></FONT>&nbsp; =
<BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>=93The presence of bands in =
positions not=20
      corresponding to well-known virus antigens is a rather common =
finding and=20
      we suppose it is the consequence of contaminants in the =
preparation...=94=20
      =93The molecular weight of these aberrant bands may vary either =
from company=20
      to company or even from lot to lot of the same producing =
company=94=20
      (2).</FONT></FONT>&nbsp; <BR><FONT face=3DArial,Helvetica><FONT =
size=3D-1>Here=20
      is Zolla-Pazner's comment in 1989: =93A confusion on the =
identification of=20
      these bands (note: the results of the Western Blot test ) resulted =
in=20
      incorrect conclusions in experimental studies. [...] A =
re-interpretation=20
      of the already published results could be necessary=94(9). =
Re-interpretation=20
      that has never been made.</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>D) The bands considered =
=93specific=94 in=20
      many cases does not indicate an HIV infection. Some examples=20
      follow.</FONT></FONT>&nbsp; <BR><FONT face=3DArial,Helvetica><FONT =
size=3D-1>-=20
      Even if the more restricting criteria were employed, Lundberg =
noticed that=20
      10% control sera, which included blood samples from blood banks, =
had a=20
      positive WB (6).&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>-&nbsp; A study(10) shows =
that from 2=20
      to 49% tested patients can have a reaction to the WB (unspecified =
WB),=20
      more frequently caused by cross-reacting =
antibodies.</FONT></FONT>&nbsp;=20
      <BR><FONT face=3DArial,Helvetica><FONT size=3D-1>- A simple =
vaccination=20
      against flu can give a positive result too =
(11).</FONT></FONT>&nbsp;=20
      <BR><FONT face=3DArial,Helvetica><FONT size=3D-1>&nbsp;- =
Transfusion of own=20
      irradiated blood induces the formation of the same antibodies=20
      (12).</FONT></FONT>&nbsp; <BR><FONT face=3DArial,Helvetica><FONT =
size=3D-1>-=20
      Among the homosexuals and bisexuals who resulted negative for =
ELISA and=20
      PCR,&nbsp; 20%-30% can have either one or more bands present in =
the=20
      Western Blot.(2)</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>- There are even more amazing data concerning dogs and =
published=20
      in 1990. Writing on Cancer Research, Strandstrom at al. reported =
that=20
      72/144 (50%) dog blood samples obtained by the Veterinary Hospital =
of the=20
      University, California, and tested with the Western Blot reacted =
with one=20
      or more HIV&nbsp; recombinant proteins [gp120--21.5%, gp41--23%,=20
      p31--22%.p24--43%]=94(13). As the Authors think that dogs can not =
be=20
      infected with HIV, one must conclude that these data are a further =
prove=20
      of the frequent antibody cross-reaction with many proteins =
different from=20
      HIV ones=94.</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>Remarks: The fact that the bands are considered =
unspecific if they=20
      are found separately, but virus-specific if they are present in a =
number=20
      of two or more, seems to refer not to considerations of a =
biological kind,=20
      but to a convention, a legal agreement changeable in time and =
space (in=20
      fact it is different from nation to nation). According to a =
convention=20
      accepted since a few time ago by many authors, three bands in a =
clinically=20
      healthy blood donor's WB were considered false positive reactions. =

      According to the same convention, three bands of the same blood =
donor,=20
      this time presented to an Insurance Company for a life policy,=20
      should&nbsp; be considered true positive.</FONT></FONT>&nbsp; =
<BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>The researchers group from =
Perth who=20
      analyzed in depth the WB meaning, concluded that the proteins =
considered=20
      viral proteins are not peculiar to HIV, but one cannot distinguish =
them=20
      form proteins of a cellular source. In particular, according to =
the review=20
      by Eleopulos et al.(14) which has not yet been refuted up to now, =
the gp41=20
      should correspond with actine; the p18 and p24/25 with the two =
myosin=20
      sub-units (p24 is the unspecific band found more frequently in=20
      =93uninfected=94 individuals); the p32 should be identical to the =
beta chain=20
      of the antigen DR of the histocompatibility class II; the =
gp120-160 should=20
      not be other than gp41 oligomers.</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>The p24=20
      antigen</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>In U.S.A. the =
evaluation of=20
      the p24 antigen capture test was included among the assays which =
are=20
      carried out to each blood unit (and it is considered as an =93HIV =
direct=20
      evidence=94). Fauci et al.(2) think that: a) the p24 corresponds =
to virus=20
      capsid antigen (core) which is highlighted by a serum containing =
the=20
      related monoclonal antibodies (anti-p24) associated to a detector =
system;=20
      b) however the test is not useful like a primary screening mean in =

      establishing a precocious HIV infection diagnosis; c) the p24 =
level=20
      increasing corresponds presumably to the blast in virus =
replication, which=20
      can be observed by other methods like plasma viraemia; d) the p24 =
level=20
      usually falls under the determination threshold with conventional =
methods=20
      and like the antibody anti-p24 starts developing during =
seroconvertion and=20
      can remain in that state during the following asymptomatic =
infection=20
      years. Only 20-30% of the individuals with asymptomatic infection =
has=20
      detectable levels of p24 serum.&nbsp;&nbsp;</FONT></FONT>&nbsp; =
<BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>However there are many =
perplexities on=20
      its real meaning. Quantity data indicate that 50 pg and sometimes =
more of=20
      core protein (p24) may be found in seropositive patients. If a =
retrovirus=20
      weight is of 10-3 pg and half of its weight is constituted&nbsp; =
by p24=20
      (15), then this quantity corresponds to about 100,000 viral =
particles,=20
      according to other authors and on other premises even to 500,000 =
particles=20
      (16)! Then if all this protein came from virions, these patients =
should be=20
      highly viraemic (17, 18). In other words there should be a direct=20
      correspondence among the p24 levels, =93virus isolation=94, =
=93viral RNA=94 levels=20
      (said also =93viral load=94). On the contrary it is not so. =
Results are=20
      irremediably different from the ones one should expect. For =
example a=20
      paper reports the presence of antigenaemia, but that no virus =
could be=20
      isolated by 31 antigenaemic patients, even after an extended =
culture=20
      (19).</FONT></FONT>&nbsp; <BR><FONT face=3DArial,Helvetica><FONT=20
      size=3D-1>Other studies report similar remarks. We shall mention =
some of=20
      them:&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>1) in half of the cases when a person had a positive =
test,=20
      afterwards he had a negative one without making any treatment =
which could=20
      alter the p24 levels... the test is clinically&nbsp; erroneous and =
should=20
      be interpreted with much caution=94.(20)</FONT></FONT>&nbsp; =
<BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>2) the p24 antigen is found =
neither in=20
      all seropositive subjects nor in individuals with clear AIDS. In a =
study ,=20
      the PCR (Polymerase Chain reaction) and p24 were used to detect =
HIV in=20
      patients in in various stages, from asynptomatical to AIDS =
individuals.=20
      They found the p24 in 24% and&nbsp; HIV-RNA in 50% of patients=20
      (21).</FONT></FONT>&nbsp; <BR><FONT face=3DArial,Helvetica><FONT =
size=3D-1>3)=20
      More than 29% of the patients who receive a transfusion from =
seronegative=20
      individuals, become positive for the anti-p24 antibody (22), even =
=93on=20
      infection absence=94.&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>4) The unspecificity of the =
p24 antigen=20
      assay is so obvious to be accepted by an authority recognized in =
the=20
      field, Philip Mortimer.et al- from Public Health Laboratory =
Service in=20
      England.=94 =93Experience proved that neither virus culture, nor =
p24 tests are=20
      of great value in diagnostic tests. They can be either insensible =
or=20
      unspecific=94 (23).&nbsp;</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT =
size=3D-1>Conclusion</FONT></FONT>&nbsp;=20
      <BR><FONT face=3DArial,Helvetica><FONT size=3D-1>The antibody =
tests (the=20
      ELISA, Western Blot and p24 antigen capture assay) for the many =
reasons=20
      over explained, are non able to indicate with reasonable assurance =
they=20
      can face an HIV infection and so the assertion that WB positive =
predictive=20
      value (24) can be considered higher than 99% does not correspond =
with=20
      reality. These tests show reactions of a variable or rather =
undetermined=20
      specificity, so that they cannot allow a distinction between=20
      cross-reaction and =93HIV infection=94.</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>THE DIRECT=20
      IDENTIFICATION&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>OF THE =
VIRUS</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>It is a common =
conviction that=20
      the antibody tests should be ratified and in a certain way =
verified from=20
      other ones which are able to highlight the virus itself, tests =
able to=20
      identify it directly. However, this direct determination is such =
only=20
      apparently. It can only record some phenomena which are considered =

      associated to the HIV in an unequivocal way. Virus direct =
identification=20
      is divided into 2 main categories (2): the virus culture and the =
direct=20
      identification of the viral nucleic acids (Southern Blot, =
amplification=20
      techniques like the PCR,TR PCR, bDNA, NASBA).</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>The viral=20
      culture</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>Usually virus =
isolation=20
      involves a patient's cell co-culture with a donor's uninfected =
cells which=20
      have been stimulated with phitoemoglutinine (PHA) for 3 days. =
These=20
      co-cultures are controlled about every 3 days for 28 days or more =
to=20
      control either the syncitia formation and p24 presence or the =
reverse=20
      transcriptase (RT) in culture supernatant (2). The presence either =
of=20
      syncitia (a) or the p24 antigen (b) or the RT (c) is considered a =
virus=20
      replication evidence (2). According to Gallo et other authors even =
the=20
      finding of virus-like particles in culture must be considered a =
sufficient=20
      criterion.&nbsp;</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>a) The appearance =
of=20
      sincytia.&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>Sincytia appearance is observed only in considered =
infected=20
      cultures, but these are present even in =93uninfected=94 cell =
lines and are=20
      similar to the ones used for HIV (25). Then such morphological =
feature=20
      could be a characteristic either of the same cell lines, or of the =
result=20
      of the culture conditions or both these factors =
(14).</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>b) The p24=20
      antigen.&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>Its specificity lack has already been mentioned. The =
objections to=20
      use it like a test on the patient's serum are efficacious even for =
its use=20
      in cultures. In a study where this =93virus isolation=94 method =
was employed (=20
      the determination of the p24 in cultures with unfractioned entire =
blood),=20
      positive results were obtained in 49 of 60 =93presumably =
uninfected but=20
      serologically undetermined individuals=94(82%) and in 5 of 5 =
seronegative=20
      blood donors (26).</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>c) The reverse =
transcriptase=20
      (RT).&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>In all the HIV research, the ability of copying =
template-primer=20
      A(n)dT15 - when it is incubated with the supernatant or material =
coming=20
      from infected material co-cultures with the AIDS virus which =
separates at=20
      a 1.16 gm/ml level (sucrose density gradient) - is considered the =
proof of=20
      a reverse-transcriptase activity of HIV. In many cases this =
activity is=20
      considered synonymous of =93HIV isolation=94 . However: also the=20
      template-primer itself is copied when it is incubated with =
material which=20
      separates in 1.16 band from leukemic cell cultures (27) and =
uninfected=20
      spermatozoa(29); b) the template-primer A(n)dT15 can be =
transcripted not=20
      only by RT, but also by other DNA cell polymerases. All the DNA =
cell=20
      polymerases, alfa, beta and gamma are able of copying the A(n)dT15 =
(29).=20
      In fact. in 1975, an International Conference on DNA which =
included=20
      Baltimore and Gallo (30) on eukariotic polymerases defined the DNA =

      polymerase gamma, =93a normal cell component=94 (31) which =
activity can be=20
      increased by many factors including the PHA stimulation (32), an =
enzyme=20
      which =93copies the A(n)dT15 with high performance, but does not =
copy well=20
      the DNA=94 (33). From what over explained we may deduce that it is =
wrong to=20
      affirm that such an enzyme activity is peculiar of retroviruses, =
and less=20
      that this is an unequivocal index of the presence of HIV. =
Particles and=20
      proteins which separate at 1.16 mg/ml band level could reflect =
fully=20
      unviral material, most of the same material is certainly cellular =
and=20
      coming from cultures stimulated with PHA (as we shall see better =
later),=20
      since transcriptase activity could derive from =
it.</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>d) Objects with a =
retrovirus=20
      appearance.&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>Gallo considered the finding of retrovirus-like =
particles in=20
      culture like the proof of the HIV isolation (at that time =
HTLV-III) (34).=20
      However Gallo used H9 (HUT78) cell line to isolate HTLV-IIIB, and =
this=20
      cell line releases retrovirus-like particles even when it is not =
infected=20
      with HIV=94 (35). Weiss obtained his =93isolate CBL-1 from the =
leukaemic cell=20
      line CEM, a cell line which hosted retroviruses even when they =
were not=20
      infected with =93HIV=94(36). In 1970, these particles were =
frequently observed=20
      in leukaemic tissues (37), in embryonic tissue cultures (38, 39) =
and in=20
      most if not in all human placenta (40). Mature and *extrobended* =
particles=20
      of the C pattern appear in linphoma cells which are metabolically =
damaged=20
      but are not infected with HIV (41). =93Retrovirus particles=94 =
antigenically=20
      similar to HIV were found in extracts from Sjorgen syndrome =
patient's=20
      salivary glands(42). And more important thing, in the only study =
of=20
      electron microscopy(43), both in vivo and in vitro where suitable =
controls=20
      were used and where an extensive assay in cieco of controls and =
test=20
      material was made, =93virus particles indistinguishable from HIV =
were found=94=20
      in a variety of reactive linphoadenopathies which are not =
HIV-associated,=20
      so that the authors concluded: =93The presence of such particles =
does not=20
      indicate, for itself, an HIV infection=94(pict =
4).</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>Conclusion: it is =
inevitable=20
      to agree that neither syncitia presence, nor p24 finding, nor =
reverse=20
      transcriptase activity, nor virus-like particle presence (well, =
each=20
      element which settles that an HIV culture is positive) are =93a =
virus=20
      replication evidence, though just this is the significance given =
to=20
      it.</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>Direct =
identification of the=20
      nucleic acids&nbsp;&nbsp;</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>For direct =
identification of=20
      the nucleic acids one intends the Southern Blot, PCR techniques, =
the=20
      quantitative amplification techniques (RT PCR, bDNA, NASBA). The=20
      identification is based on the identification and amplification of =
little=20
      nucleotide sequences attributed to HIV, not of the entire viral =
genome.=20
      This research is made not on cultures, but direclty on patient's =
tissues=20
      (including blood).</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>a) Southern blot =
technique=20
      (technique which allows to separate and highlight nucleic acids of =
the=20
      searched kind).&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>In 1984 Gallo carried out =
the first=20
      study. Using the Southern blot hybridization technique (capable=20
      theoretically of identifying only one infected on ten cells), AIDS =

      patient's tissues were examined, but weak bands were found only in =
a=20
      minority of them (44).</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>b) The PCR =
(polymerase chain=20
      reaction).&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>The PCR sensibility is valued 92-100% (45) and is able =
to detect=20
      one =93infected=94 cell on 100.000 (2). However, =93for its high =
sensibility, it=20
      is greatly liable to false positivity either for even minimum=20
      contaminations or other common laboratory mistakes=94 (2). =
Retrovirus-like=20
      sequences can be found in human genome in every cell (46). Already =
in=20
      1991, Imagawa and Detels pointed out a&nbsp; potential fallacy of =
the PCR.=20
      =93The determination of a part of the genome- they affirmed- does =
not mean=20
      to detect an entire virus=94 (47).</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>The problem of the =
false=20
      positives.&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>Many researchers challenge the PCR reability for the =
great number=20
      of false positive that this test should produce(48). The PCR did =
not prove=20
      reproducible and false positives and false negatives were observed =
in all=20
      the 7 reference laboratories involved in an important French study =
(the=20
      concordance with serology varied from 40% to 100%). Moreover, the =
number=20
      of positive results was not significally different among high and =
low risk=20
      seronegatives (49). There are many other confirmations to these=20
      remarks:&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>1) A validity study in evaluating the HIV PCR =
performance and=20
      in&nbsp; identifying free-cell viral&nbsp; DNA showed =93a =
disturbing high=20
      rate of unspecific positivity=93 employing commonly used primers =
(SK38, both=20
      for the p24 and the gag gene). Really, similar positivity rates =
were found=20
      either for antibody negative samples than for antibody negative=20
      samples(18% against 26%) (50).&nbsp;</FONT></FONT>&nbsp; <BR><FONT =

      face=3DArial,Helvetica><FONT size=3D-1>2) the PCR (qualitative =
DNA-PCR) made=20
      on uninfected infants appeared positive on many occasions=20
      (51).&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>3) In a PCR validity study coordinated by the OMS Work =
Group on=20
      the PCR, 54% of involved laboratories had problems with false =
positive=20
      results; 9.3% of uninfected samples were reported as=20
      positive(52).&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>4) The authors of a =
multicenter study=20
      of quality evaluation stated =93this study showed that false =
positive=20
      results, in spite of rigorous procedure algorithms, happen among=20
      uninfected individuals with such a frequency to remain a serious=20
      problem=94(53). The discover of a considerable number of =93false =
positives=94=20
      gives evidence of a remarkable PCR specificity =
lack.</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>c) Quantitative=20
      techniques.&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>The =93quantitative=94 techniques=94 should be able to =
calculate, in an=20
      approximate way, the number of virions per&nbsp; milliliter of =
plasma=20
      using opportune modifications of some amplification techniques =
(either=20
      substrate amplification, like RT-PCR and NASBA, or signal =
amplification,=20
      like bDNA.The substrate consists in =93preserved regions=94 of a=20
      virus-presumed gene. The calculated sensibility is: for the RNA =
RT-PCR of=20
      100 HIV RNA copies per milliliter of plasma(2); for NASBA of 1,000 =

      molecules per milliliter (54); for bDNA (branched DNA) of 10,000 =
molecules=20
      per milliliter (2). Up to 1994 HIV was considered to be present in =
small=20
      quantities in asymptomatic and AIDS subject's tissues (1 =
lymphocyte on=20
      1,000-100,000). In 1995 two studies (55, 56) seemed, on the =
contrary, to=20
      show that HIV replicated with much activity since from the first =
phases of=20
      the infection. The over-mentioned techniques in appearance allowed =
huge=20
      virus quantities, which in a first time had escaped from =
observation, to=20
      be detected.</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>However if a massive infection were present in infected=20
      individuals, as some of the most known experts claim, the Southern =
blot=20
      hybridization would have been more than sufficient to detect it. =
Don't=20
      forget that =93either virus DNA scarcity or lack in a considerable =
patient's=20
      part was a surprising result=94(57). A John Maddox' significant =
Freudian=20
      slip confirms suspects: according to Maddox =93both Ho than Wei =
and their=20
      colleagues were able to come to their alarming conclusions only =
after a=20
      ten years research of the HIV as they teamed up with =
mathematicians and=20
      because they were able to use new techniques to detect the low =
levels of=20
      virus involved =93(58)!</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>Logical incompatibilities =
of results=20
      are macroscopic and evident.&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>A) In fact there is a lack =
of=20
      correlation between p24 and gene amplification techiniques. (We =
have=20
      already mentioned the fact that the p24 is considered to be =93 =
the direct=20
      proof of HIV identification=94).</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>A) No relation was =
found=20
      between the p24 level and the RT-PCR (59). The determination of =
the viral=20
      charge was highly sensible when it was compared with the p24 =
measurement=20
      (more than 95% of patients had detectable virus charge while only =
40% had=20
      detectable p24), but in positive samples antigen and viral charge =
level=20
      had only a borderline significance (60).&nbsp;</FONT></FONT>&nbsp; =

      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>B) No relation was =
observed=20
      between viral charge quantified either with the NASBA or the =
Amplicor and=20
      the concentration with the p24 antigen. No relation was observed =
between=20
      the infectious dose, the viral virl load found either with the =
NASBA or=20
      the Amplicor(RT-PCR) (61).</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>C)There is a =
relation lack=20
      between RT-PCR and other assays. In a study on vaccinated =
subjects, a=20
      group of four serum samples resulted positive with RT PCR during a =
11=20
      months period, including a result of 104-105 copies/mL, and an =
year later=20
      a fifth positive result in a vaccinated subject, but not =
infected=94 (62).=20
      For this reason, the authors advanced =93doubts concerning =
specificity of=20
      HIV RNA measurement as a golden standard for the screening and the =

      infection confirmation=94.</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>D) There is =
finally a lack of=20
      correlation between =93virus=94 and =93viral =
load=94.&nbsp;</FONT></FONT>&nbsp;=20
      <BR><FONT face=3DArial,Helvetica><FONT size=3D-1>1) According to =
Piatak, the=20
      high =93virus=94 level in plasma was 999 per 1,000 =
=93unculturable=94=20
      (63).&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>2) Ho et al. showed that 10,000 plasma =93virions=94 =
counted with the=20
      branched PCR correspond with less than one =93infectious=94 virus =
per ml (64).=20
      3</FONT></FONT>&nbsp; <BR><FONT face=3DArial,Helvetica><FONT =
size=3D-1>) In a=20
      more recent study by Ho (65) one may notice that 0 (zero!) =
=93cultured=20
      viruses=94 corresponded to a load of 500,000 units! According to =
the=20
      reported data, to patient 105 before the treatment (with =
Ritonavir)=20
      643,000 =93virions=94/ml were detected, where the number was =
calculated with=20
      the branched DNA assay, more than 1,000 TCID-50/ml corresponded to =
it (50%=20
      tissue culture infectious doses). After a two day therapy and in =
following=20
      days the =93cultivable virus=94 was 0(zero). In the meantime, at =
2, 3 and 4=20
      days =93free virions=94 (that is the so-called =93viral charge=94) =
remained over=20
      500,000. Till 7 day =93virions=94 were again over 100,000. A =
virion is defined=20
      as a complete viral particle constituted with the viral nucleic =
acid,=20
      capsid and pericapsid (when present). The possible objection for =
which a=20
      defective virion is =93seen=94 by branched DNA assay, but is not =
detected by=20
      culture samples, does not resolve the problem of =
non-correspondence with=20
      the other tests and the impossibility of seeing these particles at =
the=20
      microscope directly from patient's tissues, without culture =
transfers. If=20
      it were so, Gallo would not need for applying to frauds (67, 68), =
he would=20
      not call for three year tireless researches in order to find =
something=20
      which had the appearance of a virus. He would have come to it =
immediately=20
      with other researchers.</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>Mark Craddock, professor at =
the School=20
      of Mathematics and Statistics, The University of Sidney, Australia =

      commented: =93What is this viraemia of billions of RNA particles =
that can=20
      only be seen with an undocumented branch-PCR or PCR but not with a =

      functional infectivity test?=94. (68)</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>VIRAL=20
      GENOME</FONT></FONT>&nbsp; <BR><FONT face=3DArial,Helvetica><FONT=20
      size=3D-1>&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>As already stated, genomic amplification techniques =
concern small=20
      segments, not surely the complete =93viral=94 genome and the =
results which are=20
      obtained do not give the assurance to have the true =93HIV=94, =
besides they=20
      are frankly discordant. At this point it's legitimate to ask what =
is=20
      really and how it's made the original viral genome. The reserch =
group from=20
      Perth (69) notes that if an unique AIDS retrovirus existed, then =
less than=20
      1% genomic differences should be the rule, not the exception. For=20
      instance, the type 3 Sabin poliovirus vaccine differed from its=20
      neurovirulent progenitor at only 10 nucleotide positions after 53 =
in vitro=20
      and 21 in vivo passages in monkey tissues. In 1977, H1N1 influenza =
A virus=20
      reappeared in the human population after 27 years of dormancy with =

      sequences mainly identical to those of the 1950s virus=94. =
Although Eigen's=20
      quasispecies model has been used to describe the genome of RNA =
viruses,=20
      even 1% sequence differences in these genomes are considered to =
represent=20
      =93extreme variability=94. =93Many selective forces may stabilize =
virus=20
      populations. These stabilizing factors may include the need for=20
      conservation of protein structure and function, RNA secondary =
structure,=20
      glycosylation sites, and phosphorylation sites=94. Let us see what =
is the=20
      picture offered by HIV research. Not long afterwards it was =
discovered=20
      that =93If you were to test two HIVpositive people at random and =
analyse the=20
      genetic material of their strains, they would differ, on average, =
by about=20
      13 percent=94 (70). Besides what is considered to be the genotype =
of HIV=20
      comes from sequence analysis of subgenomes that&nbsp;&nbsp; HIV =
genotype=20
      consignments are derived from sequence analysis of subgenomes =
measuring 2%=20
      to 30% of the total (71). The data is that such =93genomes=94 vary =
between=20
      3-40% (72,73). =93If 30% of the HIV genome varies as much as 40%, =
how much=20
      does 100% of the HIV genome vary? This is the legitimate question =
of=20
      Eleopulos and colleagues (69).</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>Among researchers there is =
disagreement=20
      also about the number of HIV genes. In 1988 they said HIV genome =
had eight=20
      genes (74), in 1990 ten (75). In 1996 Montagnier referred that HIV =
had=20
      eight genes (76), and according to Barr=E9-Sinoussi, HIV has nine =
genes (77)=20
      Not even the number of nucleotides of HIV genome seems to be =
constant=20
      (69)</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>HIV=20
      quasi-species&nbsp;</FONT></FONT>&nbsp;=20
      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>Because great =
genomic=20
      differences were found - even the same person can harbor more than =
106-108=20
      genetically distinct variants (78) - to try to find a =
justification for=20
      this phenomenon, the concept of quasi-species has been introduced. =
Prior=20
      to the 1990s, the HIV sequences were classified as African and=20
      USA/European with sequence differences of 20-30 percent between =
these two=20
      groups. (79). In the 1990s, HIV researchers started to divide the =
=93HIV=20
      genome=94 into subtypes A, B, C, D, E, etc. The basis for this=20
      classification system is: =93(a) subtypes are approximately =
equidistant from=20
      one another in env; (b) the env phylogenetic tree is for the most =
part=20
      congruent with gag phylogenetic trees; (c) two or more samples are =

      required to define a sequence subtype=94. However, =93Subtype =
naming problems=20
      have arisen. A small but not insignificant number of viral =
sequences are=20
      hybrid, clustering with one sequence subtype in gag and another =
sequence=20
      subtype in env, for example;... Naming becomes problematic when =
highly=20
      divergent forms of a given subtype arises: such forms are =
sometimes=20
      designated A', B', F', etc=94. It is increasingly necessary to =
have sequence=20
      data from both gag and env coding sequences when a new form or =
subtype is=20
      being claimed=94 (80). By the middle of 1996 =93at least ten=94 =
(A-J) prevalent=20
      major (M) and a low prevalence, O, HIV-1 genotypes were described =
and new=20
      genotypes are still reported (81,82).</FONT></FONT>&nbsp; =
<BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>Is it possible then to =
describe the=20
      =93HIV DNA=94 even if it has variation of 10% , not to mention 20 =
or 30 or 40%=20
      as is the case, as a ...=94population of closely related genomes, =
referred=20
      to as a quasispecies=94 (69)? The extreme variability of HIV =
genome make us=20
      ask what is the sense to refer to HIV as a clear distinct entity. =
The=20
      genomic difference among human being of different race is about 1 =
per=20
      1.000, between man and orang-utan about 2%, but to find a 30% =
difference=20
      is necessary to compare non the less man and mouse, man and ass, =
man and=20
      elephant! Can one consider mouse, ass and elephant as =
quasi-species of=20
      man? (pict. 5).</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>Particle detection Retrovirus are defined as particles =
of about=20
      100-120nM of diameter with a core which includes a proteic coat =
and a=20
      ribonucleoprotein complex. Retroviruses are classified in three=20
      subfamilies:&nbsp; Spumavirinae, Lentivirinae and Oncovirinae.=20
      Retroviruses belonging to the last subfamily are divided in type =
A, B, C,=20
      and D particles. To which of these should belong HIV, is not very =
clear.=20
      According Gallo in 1984, it was a type C particle, but in 1985 he =
admitted=20
      it could be also a type D (83). Montagnier and coll. initially =
reported it=20
      was a type C particle (84), then a type D (85), and then a =
lentivirus=20
      (86), that is to say a different subfamily. According to Munn and =
others=20
      AIDS virus shows characteristics of type C, of type D and of =
lentivirus=20
      (87). Fauci and others described HIV in monocyte/macrophages =
cultures as=20
      retroviral particles with characteristics of type A (88). HIV =
identity=20
      seems to be so vague, so =93shot=94, that it adds further reasons =
of=20
      perplexity. Photographs Several researchers in the AIDS field have =
shown=20
      HIV photographs, but those that can be seen are only virus-like =
viral=20
      particles indistinguishable from normal cellular microvescicles. =
These=20
      particles, in contrast with viruses, are very unstable when =
removed from=20
      their contest, and it's difficult to isolate them and photograph =
them in a=20
      condition of a true isolation. On the contrary, viruses are stable =
because=20
      they have to leave again the cells and host organisms. The use of=20
      centrifugation techniques doesn't constitute a problem to separate =
viruses=20
      from various contaminants and so get their isolation - then =
photograph=20
      them, to put in evidence their proteins and their genetic =
constituents in=20
      a direct way. True viruses are so stable that it's easy to =
photograph=20
      directly them as tridimensional particles by an electronic =
scanning=20
      microscope, without the need to first fix them chemically. On the=20
      contrary, the microvescicles are so unstable that can be =
photographed only=20
      by a transmission electronic microscope which requires that they =
be=20
      previously fixed chemically in ultra-thin sections. What has been =
shown to=20
      the world as HIV micro graphs are ultra thin sections which =
include=20
      particles indistinguishable from the cellular ones (89) (pict=20
      6-8).</FONT></FONT>&nbsp; <BR><FONT face=3DArial,Helvetica><FONT =
size=3D-1>The=20
      evidence of HIV (non-)existence A noteworthy confirmation to the =
argued=20
      critics of the researchers from Perth came in march 1997: two =
groups, one=20
      French/German (90) and one from the American NCI (91), have =
published the=20
      photographs of density gradients in which pure HIV virus had to be =
present=20
      (pict. 9). These data should have been available by the first =
isolation of=20
      the virus (1983-84), but nobody showed them before. The most =
likely reason=20
      is the lack of correspondence between what they found and what =
they=20
      expected.</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>In the Franco/German study the&nbsp; pictures are from =
the 1.16=20
      gm/ml band. It is impossible to tell from which density the =
pictures in=20
      the American study are taken but presumably it's the same 1.16 =
density for=20
      retroviral particles. Eleopulos and colleagues note that =93. The =
authors of=20
      both papers concede that the particles which are present in the=20
      banded&nbsp; material and which are said to be HIV represent only =
a very=20
      small fraction of the total&nbsp; material. Gelderblom et al. =
state that=20
      the material contains =93an excess of [cellular] vesicles with a =
size range=20
      50-500nm, as opposed to a minor population of virus particles... =
cellular=20
      vesicles appear... to be a major contaminant of HIV preparations =
enriched=20
      by sucrose gradient centrifugation=94. =93For the small number of =
particles=20
      deemed to be =93HIV=94 no evidence is given that they are even a=20
      retrovirus-like particle. Indeed, to the contrary: (a) the =
particles do=20
      not appear to have surface spikes (knobs)... In other papers =
published by=20
      many researchers including Gelderblom and his associates such =
projections=20
      are noted to be absent (93, 94); (b) the particles referred to as =
=93HIV=94=20
      are not spherical and have diameters exceeding 100-120 nM. In the =
EM in=20
      Gluschankof et al. (90) there are arrows pointing to five&nbsp; =
=93HIV=94=20
      particles devoid of surface projections whose dimensions are 121 X =
145;=20
      121 X 169; 121 X 145, 121 X 145 and 133 X 145 nM=20
      respectively.&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>In Bess et al. (91) there =
are a total=20
      of six =93HIV particles=94 also devoid of surface projections =
whose dimensions=20
      are 160 X 240; 200 X 240; 280 X 280; 208 X 250; 167 X 250 and 250 =
X 292=20
      and nM respectively. =93Actually, the authors maintain these are =
HIV=20
      particles, but without any proof. In the material of that density =
band=20
      there ought to be many viral particles, on the contrary they point =
only=20
      some, among many impurities.&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>They bear only the vaguest =
resemblance=20
      to retroviral particles=94. =93The point is that any genuine =
retroviral=20
      particle contains a fixed amount of RNA and protein. No more and =
no less.=20
      This means that if we consider diameters of particles pointed in =
the two=20
      studies, they are&nbsp; 1.14 times to 1.96 times larger than the =
estimated=20
      maximum for a normal HIV particle. Translating this in volumes, =
and=20
      comparing them to a particle with a diameter of 120nM,&nbsp; the=20
      Franco/German particles have 50% more volume than a retroviral =
particle=20
      and the US particles have 750% more volume=94, that is to say =
incompatible=20
      with the same definition of a retrovirus! Even if the authors do =
not admit=20
      it, the data of the two cited papers contribute to show that where =
should=20
      be present pure HIV, of HIV there is no trace.</FONT></FONT>&nbsp; =

      <P><FONT face=3DArial,Helvetica><FONT =
size=3D-1>CONCLUSION</FONT></FONT>&nbsp;=20

      <P><FONT face=3DArial,Helvetica><FONT size=3D-1>None of the tests =
examined=20
      seems to be sufficiently sure to detect an HIV infection. =
Paradoxically=20
      not even the =93direct virus detection=94 is able to do answer to =
the same=20
      question. As a matter of facts there is an incompatible =
discordance among=20
      the results obtained with different methods. These discordances =
are by=20
      themselves logical incompatibilities that invalidate them. =
Besides, the=20
      existence of an entity that one can reasonably name =93HIV =
virus=94 is not=20
      proved, as far as its proteins, its genome, its physical particle =
are=20
      concerned. The true meaning of the tests is better understood if =
its=20
      origin is examined. To show the existence of a new virus, both =
Montagnier=20
      group in 1983 and the group of Gallo in 1984 separated supernatant =
of=20
      cultures they considered infected in density gradients. They =
erroneously=20
      considered that the material that banded at 1,16 mg/ml was =
constituted by=20
      =93pure HIV particles=94. The proteins which were present in this =
band=20
      and&nbsp; were reactive with AIDS patients sera (but not only with =
their=20
      sera) were considered HIV proteins. In the same manner, a =
particular=20
      fraction of RNA which they found in the same band was considered =
the=20
      genome of the new virus. By then, some of these proteins are used =
to=20
      get&nbsp; the reagent for some kind of tests or as immunogens to =
produce=20
      in laboratory animals the antibodies used for other kind of tests =
(&nbsp;=20
      similar procedure was followed to obtain RNA=20
      segments).&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>At this point the explanation of Gallo experiments in =
1984 appears=20
      clearer: he used a mixture of proteins (believed to be viral but =
in fact=20
      cellular) to immunize the rabbits and obtain a serum which =
obviously=20
      reacted with the same proteins that were in the culture from which =
the=20
      initial mixture came (95).&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>In other words Gallo =
believed to show=20
      an hypothesis (the existence of the virus) with other hypothesis =
shown to=20
      be false (that is to say that inverse transcription activity, the =
presence=20
      of virus-like particles, the antibodies obtained in the way just =
mentioned=20
      were all virus specific).&nbsp;</FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>In this way were born the =
tests which=20
      to-day are still used and perfectioned to put so engaging a =
diagnosis. An=20
      important prove of the correctness of this interpretation of the =
facts=20
      stays in the results that they obtained on mice and monkeys in =
1991=20
      (96).&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>In those studies, with the scope to evaluate a candidate =
vaccine,=20
      some laboratory animals were injected with cellular components =
from=20
      cultures which were =93not infected by HIV=94: the results were =
similar to=20
      those obtained with =93the real vaccine=94 (i.e. with virus from =
=93infected=20
      cultures=94).&nbsp;</FONT></FONT>&nbsp; <BR><FONT =
face=3DArial,Helvetica><FONT=20
      size=3D-1>No significant difference was found, so that the comment =
-=20
      perfectly suited&nbsp; and still up to date of John Maddox - was: =
=93AIDS=20
      research turned upside down=94.&nbsp;</FONT></FONT>&nbsp; =
<BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-1>That is to say that it =
wasn't necessary=20
      at all to hypothesize the presence of a virus to obtain those=20
      phenomena.</FONT></FONT>&nbsp;=20
      <P><B><I><FONT face=3DArial,Helvetica><FONT color=3D#000000><FONT=20
      size=3D-1>Fabio Franchi</FONT></FONT></FONT>&nbsp;</I></B>&nbsp; =
<BR><FONT=20
      face=3DArial,Helvetica><FONT color=3D#000000><FONT =
size=3D-1>Specialista in=20
      Igiene,&nbsp;</FONT></FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT color=3D#000000><FONT =
size=3D-1>Medicina=20
      Preventiva&nbsp;</FONT></FONT></FONT>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT color=3D#000000><FONT size=3D-1>e in =
Malattie=20
      Infettive</FONT></FONT></FONT>&nbsp; <BR><B><FONT=20
      face=3DArial,Helvetica><FONT color=3D#000000><FONT=20
      size=3D-1>Trieste</FONT></FONT></FONT></B></P></TD>
    <TD vAlign=3Dtop align=3Dleft width=3D"10%">
      <CENTER>&nbsp;</CENTER>
      <CENTER>
      <TABLE cols=3D1 width=3D150 bgColor=3D#333333 border=3D1>
        <TBODY>
        <TR>
          <TD>
            <CENTER>&nbsp;</CENTER>
            <CENTER><A =
href=3D"http://www.cesil.com/0898/frhimg1.htm"><IMG=20
            height=3D64=20
            =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/fraimg1p.jpg"=20
            width=3D100 align=3DABSCENTER border=3D1></A></CENTER>
            <CENTER><FONT face=3DArial,Helvetica><FONT =
color=3D#ffffff><FONT=20
            size=3D-1>Fig.=20
      1</FONT></FONT></FONT></CENTER></TD></TR></TBODY></TABLE></CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>
      <TABLE cols=3D1 width=3D150 bgColor=3D#333333 border=3D1>
        <TBODY>
        <TR>
          <TD>
            <CENTER><A =
href=3D"http://www.cesil.com/0898/frhimg2.htm"><IMG=20
            height=3D65=20
            =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/fraimg2p.jpg"=20
            width=3D100 align=3DABSCENTER border=3D1></A></CENTER>
            <CENTER><FONT face=3DArial,Helvetica><FONT =
color=3D#ffffff><FONT=20
            size=3D-1>Fig.=20
      2</FONT></FONT></FONT></CENTER></TD></TR></TBODY></TABLE></CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>
      <TABLE cols=3D1 width=3D150 bgColor=3D#333333 border=3D1>
        <TBODY>
        <TR>
          <TD>
            <CENTER><A =
href=3D"http://www.cesil.com/0898/frhimg3.htm"><IMG=20
            height=3D77=20
            =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/fraimg3p.jpg"=20
            width=3D100 align=3DABSCENTER border=3D1></A></CENTER>
            <CENTER><FONT face=3DArial,Helvetica><FONT =
color=3D#ffffff><FONT=20
            size=3D-1>Fig.=20
      3</FONT></FONT></FONT></CENTER></TD></TR></TBODY></TABLE></CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>
      <TABLE cols=3D1 width=3D150 bgColor=3D#333333 border=3D1>
        <TBODY>
        <TR>
          <TD>
            <CENTER><A =
href=3D"http://www.cesil.com/0898/frhimg4.htm"><IMG=20
            height=3D59=20
            =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_33dd44b.mht!htt=
p://www.cesil.com/0898/fraimg4p.jpg"=20
            width=3D100 align=3DABSCENTER border=3D1></A></CENTER>
            <CENTER><FONT face=3DArial,Helvetica><FONT =
color=3D#ffffff><FONT=20
            size=3D-1>Fig.=20
      4</FONT></FONT></FONT></CENTER></TD></TR></TBODY></TABLE></CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>&nbsp;</CENTER>
      <CENTER>
      <TABLE cols=3D1 width=3D150 bgColor=3D#333333 border=3D1>
        <TBODY>
        <TR>
          <TD>
            <CENTER><A =
href=3D"http://www.cesil.com/0898/frhimg5.htm"><IMG=20
            height=3D80=20
            =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/fraimg5p.jpg"=20
            width=3D80 align=3DABSCENTER border=3D1></A></CENTER>
            <CENTER><FONT face=3DArial,Helvetica><FONT =
color=3D#ffffff><FONT=20
            size=3D-1>Fig.=20
      5</FONT></FONT></FONT></CENTER></TD></TR></TBODY></TABLE></CENTER>
      =
<CENTER>&nbsp;</CENTER></TD></TR></TBODY></TABLE></CENTER>&nbsp;<FONT=20
face=3DArial,Helvetica><FONT size=3D-1>&nbsp;</FONT></FONT>=20
<TABLE cols=3D2 cellPadding=3D3 width=3D700 border=3D0>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop><FONT size=3D-1><B><I><FONT =
face=3DArial,Helvetica><FONT=20
      color=3D#006600>&nbsp;Leadership =
Medica</FONT></FONT></I></B><SUP><FONT=20
      face=3DArial>=AE</FONT></SUP>&nbsp;</FONT>&nbsp; <BR><FONT =
size=3D-1>&nbsp;<A=20
      href=3D"mailto:ldmedica@cesil.com"><IMG height=3D11=20
      =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/mail.gif"=20
      width=3D14 align=3DABSCENTER border=3D0></A><I><FONT =
face=3DArial,Helvetica>=20
      Mensile di scienza&nbsp; medica e =
attualita`</FONT></I>&nbsp;</FONT>&nbsp;=20
      <BR><FONT face=3D"arial, helvetica"><FONT =
size=3D-1>&nbsp;</FONT><FONT=20
      size=3D-2>Copyright 1997=A9 All Rights Reserved</FONT></FONT><FONT =

      size=3D-2>&nbsp;</FONT></TD>
    <TD>
      <DIV align=3Dright><A href=3D"http://www.cesil.com/index.htm"><IMG =
height=3D50=20
      =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_33dd44b.mht!htt=
p://www.cesil.com/0898/homeld.jpg"=20
      width=3D50 border=3D0></A></DIV></TD></TR></TBODY></TABLE>&nbsp;<A =

href=3D"http://www.cesil.com/0898/enfo08.htm"><IMG height=3D50=20
src=3D"http://83.224.70.5/www.cesil.comm/0898/bottpiue.gif" width=3D120=20
align=3DABSCENTER border=3D0></A>=20
<TABLE cols=3D2 cellPadding=3D3 width=3D700 border=3D0>
  <TBODY>
  <TR>
    <TD vAlign=3Dtop><FONT size=3D-2>&nbsp;This pages are maintened =
by</FONT><FONT=20
      size=3D-1>&nbsp;</FONT>&nbsp; <BR><B><I><FONT =
face=3DArial,Helvetica><FONT=20
      color=3D#000099><FONT size=3D-1><A =
href=3D"http://www.coloseum.com/gtmgraph">GTM=20
      Grafica</A></FONT></FONT></FONT></I></B>&nbsp; <BR><FONT=20
      face=3DArial,Helvetica><FONT size=3D-2>Service &amp;=20
      Network</FONT></FONT>&nbsp; <BR><A=20
      href=3D"mailto:gtmgraph@coloseum.com"><IMG height=3D11=20
      =
src=3D"mhtml:http://83.224.70.6/multipart/www.cesil.com_0_db8a0da5ee58b79=
52292899a3b5060af.mht!http://www.cesil.com/0898/mail.gif"=20
      width=3D14 border=3D0></A><FONT face=3DArial><FONT size=3D-2>=20
      gtmgraph@coloseum.com</FONT></FONT></TD>
    <TD vAlign=3Dtop>
      <DIV align=3Dright>&nbsp;</DIV></TD></TR></TBODY></TABLE>&nbsp; =
</BODY></HTML>

------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/migltin1.gif
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------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/tosctin2.gif

R0lGODdhJgIUAJEAAP////sAAQAAAAAAACwAAAAAJgIUAAACeoyPqcvtD6OctNqLs968+w+G4kiW
5omm6sq27gvH8kzX9o3n+s73/g8MCofEovGITCqXzKbzCY1Kp9Sq9YrNarfcrvcLDovH5LL5jE6r
1+y2+w2Py+f0uv2Oz+v3/L7/DxgoOEhYaHiImKi4yNjo+AgZKTlJWWl56VcAADs=

------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/frahtes1.jpg
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------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://83.224.70.4/www.cesil.comm/0898/frahte2e.jpg
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------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/ficapalb.jpg

/9j/4AAQSkZJRgABAgEASABIAAD/7QE0UGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABAASAAAAAEA
AgBIAAAAAQACOEJJTQPzAAAAAAAIAAAAAAAAAAA4QklNJxAAAAAAAAoAAQAAAAAAAAACOEJJTQP1
AAAAAABIAC9mZgABAGxmZgAGAAAAAAABAC9mZgABAKGZmgAGAAAAAAABADIAAAABAFoAAAAGAAAA
AAABADUAAAABAC0AAAAGAAAAAAABOEJJTQP4AAAAAABwAAD/////////////////////////////
A+gAAAAA/////////////////////////////wPoAAAAAP////////////////////////////8D
6AAAAAD/////////////////////////////A+gAADhCSU0EBgAAAAAAAgAG/+4ADkFkb2JlAGQA
AAAAAf/bAIQAAgICAgICAgICAgMCAgIDBAMCAgMEBQQEBAQEBQYFBQUFBQUGBgcHCAcHBgkJCgoJ
CQwMDAwMDAwMDAwMDAwMDAEDAwMFBAUJBgYJDQoJCg0PDg4ODg8PDAwMDAwPDwwMDAwMDA8MDAwM
DAwMDAwMDAwMDAwMDAwMDAwMDAwMDAwM/8AAEQgADwAPAwERAAIRAQMRAf/EAaIAAAAHAQEBAQEA
AAAAAAAAAAQFAwIGAQAHCAkKCwEAAgIDAQEBAQEAAAAAAAAAAQACAwQFBgcICQoLEAACAQMDAgQC
BgcDBAIGAnMBAgMRBAAFIRIxQVEGE2EicYEUMpGhBxWxQiPBUtHhMxZi8CRygvElQzRTkqKyY3PC
NUQnk6OzNhdUZHTD0uIIJoMJChgZhJRFRqS0VtNVKBry4/PE1OT0ZXWFlaW1xdXl9WZ2hpamtsbW
5vY3R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+Ck5SVlpeYmZqbnJ2en5KjpKWmp6ipqqusra6voR
AAICAQIDBQUEBQYECAMDbQEAAhEDBCESMUEFURNhIgZxgZEyobHwFMHR4SNCFVJicvEzJDRDghaS
UyWiY7LCB3PSNeJEgxdUkwgJChgZJjZFGidkdFU38qOzwygp0+PzhJSktMTU5PRldYWVpbXF1eX1
RlZmdoaWprbG1ub2R1dnd4eXp7fH1+f3OEhYaHiImKi4yNjo+DlJWWl5iZmpucnZ6fkqOkpaanqK
mqq6ytrq+v/dAAQAAv/aAAwDAQACEQMRAD8A8caJa6V5gu/MtlqHnK08m/4f017y0kuUaR7+6UAp
axBQQC1epz0T/gQf8CfsrU9i4e2O09MdWdRkMYw4uGGLHE8JnIAgyJIO17CnzP2S9m9Nq8Pj56JN
0DyofpeS+XvOV3qFzr+i3M3qXFhaS3FnfKAGogoQ3aoJBG2YP/BA/wCBp2F2Z7Rdm5NHjrS59Vix
5cRkTGpZI3wn6gJR4gd9ujR2v7PYNPqcE8Y9E8kYyj03I5P/0Pmz528uLqeoG80jzDZ6ZqoVEvLK
eZU5EfZbY1U08Rvm+/4GHtt7RdldkjSjQanUaMmRhkx4pzEb+qIIjwkcV8jsbfJvZrtXUabFwHDk
njvYxiTXlyooTyx5YsdOsvMip5ksNS80ajYTxSSRToRbAoRVqMWADEFmIzRe1ftV2rre1NFkyaPP
iw4s8JREoSE8kxIEAAgAyNVGIs2WXa3a2oz6nATgyQxwyRIBibkbHlz7g//Z

------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://83.224.70.4/www.cesil.comm/0898/ita.gif
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------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/fraimg1p.jpg
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------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/fraimg2p.jpg
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------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/fraimg3p.jpg
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------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/fraimg4p.jpg

/9j/4AAQSkZJRgABAgEBLAEsAAD/7QE0UGhvdG9zaG9wIDMuMAA4QklNA+0AAAAAABABLAAAAAEA
AgEsAAAAAQACOEJJTQPzAAAAAAAIAAAAAAAAAAA4QklNJxAAAAAAAAoAAQAAAAAAAAACOEJJTQP1
AAAAAABIAC9mZgABAGxmZgAGAAAAAAABAC9mZgABAKGZmgAGAAAAAAABADIAAAABAFoAAAAGAAAA
AAABADUAAAABAC0AAAAGAAAAAAABOEJJTQP4AAAAAABwAAD/////////////////////////////
A+gAAAAA/////////////////////////////wPoAAAAAP////////////////////////////8D
6AAAAAD/////////////////////////////A+gAADhCSU0EBgAAAAAAAgAC/+4ADkFkb2JlAGSA
AAAAAf/bAIQADAgICAkIDAkJDBELCgsRFQ8MDA8VGBMTFRMTGBEMDAwMDAwRDAwMDAwMDAwMDAwM
DAwMDAwMDAwMDAwMDAwMDAENCwsNDg0QDg4QFA4ODhQUDg4ODhQRDAwMDAwREQwMDAwMDBEMDAwM
DAwMDAwMDAwMDAwMDAwMDAwMDAwMDAwM/8AAEQgAOwBkAwEiAAIRAQMRAf/EAT8AAAEFAQEBAQEB
AAAAAAAAAAMAAQIEBQYHCAkKCwEAAQUBAQEBAQEAAAAAAAAAAQACAwQFBgcICQoLEAABBAEDAgQC
BQcGCAUDDDMBAAIRAwQhEjEFQVFhEyJxgTIGFJGhsUIjJBVSwWIzNHKC0UMHJZJT8OHxY3M1FqKy
gyZEk1RkRcKjdDYX0lXiZfKzhMPTdePzRieUpIW0lcTU5PSltcXV5fVWZnaGlqa2xtbm9jdHV2d3
h5ent8fX5/cRAAICAQIEBAMEBQYHBwYFNQEAAhEDITESBEFRYXEiEwUygZEUobFCI8FS0fAzJGLh
coKSQ1MVY3M08SUGFqKygwcmNcLSRJNUoxdkRVU2dGXi8rOEw9N14/NGlKSFtJXE1OT0pbXF1eX1
VmZ2hpamtsbW5vYnN0dXZ3eHl6e3x//dAAQAB//aAAwDAQACEQMRAD8A9VSSSSUpJUXda6W3qzej
G9v7RfX6zceDOwfnbo2dvo7leSUpJJJJSlh/Wn6wHpGG5uON+bYwmoEEtaPo+o6Ppe76DFuLO610
zDzsR7shsPpY51dw0c2Bu+l+5+8xEVYtbK+E8Jovk+X176zWY+/IzrtjXSGF20yDzt0Wrh9Rzeo4
lduRe57eWMc4kAjmyP33LJ6xjvspfZtY17Yc+ZNkfR9pd7fT/qKf1feyvHa4Tvt9sEyPZ3AVk1Qo
Bo2b1Jb/AFTrGdhtqLcixrGyK6mPcza8/wCF9h+jtVrE+s3WKXU31Zd2SJALbCH1n95r9GvasH6y
D3V2hsmQHmdG87f89av1Q6Bndby2vy2Or6VVrYRLBYY/mQ5m1/u3e9Co8NmtExMzKokve/8AOvpn
7G/au4Ru9H0ZE+v/ANx930f5W/8A0X6RJXv2P0r7B+zvstX2OI9DaNvhu/r/APCfTSUFx7Hf/mty
sncbdv0n/9D1VJJJJT4/mfWPqeL9eLs29tQzMW52J9Ea0bvbRp+c5n83d/Oe9et4uQ3KxqslrXMb
cwPDXgtcA4TDmu9zV459dWZNX11y3by2sX0WWWMafa3bS+v1Nfoer6bF1v1+691H7B0z9kZn2SrN
BvstqJFpYAw1tY6Nra3Of70kgEkAPdrK+sP1m6T9XMQZXUrS0PO2qpg3WWHwrr/k/vfQXB4/+MX6
xYrGNfXTmBjNsvBY9xA0se9h2/1/0a4rrOT1brPUDndVtN1z/a0RDWNHFdTPzGIcQX+zK9X0jA/x
xfV/KzK8bIxsjErtdtGQ/a5jZ72em4ua1dX1vPxq+g5eW2xr6fRcGvYQ4Hd+jG1zfpe5y8s6X9Qs
/Jqxb3MaKM2p1tb3D2t2GG12Ob+dktd7P+DXonTPqyMbBxOnG513S8VljmVWnc/1Xk+kN21n6vis
e/0Wu/wn/FogrZxA0Bu3zx+QXXGeSYnka6H2n81HNVGJidKa1rW25D8svu4Ltr27KzH7tao/WDBz
OjX24to/SVOBa8T7mzuZaz+tCfKz/wBUw2kh1RyK7KyfzXOGx7mO/N3sd71akNAQ50f0hLyHm7WF
g4fUH5mLbX6lzW0W1PJPHqil9P8A131F6ZjY2PiUNox2CqpghrG6Bea9B3WfWbGoDorL63vHj6Yt
sZJ/d9q9PUOS7H2tnl64Sa8FJJJKNmf/0fVUklSybXXE01T6YMWvbGp70iXs/wCuOSU8h1rFfl/W
Dq+PXjPdT1LADW5m2a/Up+jWHksY1+9m9i5vP+35vQun5WVRdj29Pb9luZaxzSWuM037nfSa/wCi
vSnVb3egwODGgepBIEfm1f0j8/8A89qp1jAoz6GdPvc9lVr2F8GJAd+jq91t387bs/MQIsLoS4ZA
vlLC99rqGtc+1oLtrAXHaBv3e3+T9JQNlZDQ6C7SB5+S9SqwenYlT9tLKw07biwCS1rWvu9zbGPe
6yfT2Lmsn6oZ9PTszGro9U/a67MfVptNIbaPd7va9jLGv2JnC2I5gd9NnpOivvb9WsCkwWiqtzXS
A4bjub/hfzN37q1Tm5VNbQ1rS0FrTMTBO3d/OqD6GVYja2M2srDGtAA0DS0D/DomRUTTYA2DtJBg
cj3f6ZSNYmy8V9farbMtmTaJF2O6sNERLCXfmus/0i5jNxacVlOPkWiunHfW9zncGGssaP8AOeu+
+t+Bfm4mK7Hq37HucdoH0XN/kvsXHdW6dZ1C2rCv3Ueo6mm20N3bSxraX27Pbvbp7/exTwkOEC+h
aeSP6w+JGrofUe+vO+sVOSw/owXhhOkhjHMb/nvsXqS8x+oPTxj5f2dzXODKrQx7m7TO9sP2ve30
3bRvb716Ni3ueDVbpcznj3N/Ns9hc33JmU+r6M2AVE+ZbCSSSjZX/9L0rKyPd6FZc0ke+xrXP2j9
32D+ccqtn2djQ1jGue7RjTju+bj/AFfpPT4vq+lp9pjc6I9Oef8ACbvd6v76f9L9q/7UT6ff093P
5v5u39//AK2kpyXdSpqstprqD3UEjaaGy90jc633bvfu3Maxi0Ps1VtJLwabXuFjXMxzurc2HV7D
t2/o9qzrY/aukb/Ud4759nj+i3/6X/Brc/Tf92v/AAJMgJXLiN9uy6XDQoNHHxKN9/qOOQHOI3Px
zMu99o/RMr/O/tp7mCm2h2Mw22ML3ua5ljXPbt9Jwdc8Wv8A8I1WaPV2GPtEb3/R9P8Aedzu/O/e
TH1ftTf6RPpu/wBHujcz+ynrUDw37G820tY8TA9Au0DvZNgaxv0VZ2Y8/wA23/2Gco5Xq/ZrJ+0x
tM7vTj57Pci/pv8Au1/4Ekpr4zaBS1uwHZLJ+zOJ9p2a6JMbQy97PTHv/SN/V3T+7Z/33/PU8f1f
0sfaP5x07fT50/e/O/qpP9X16v6RPuifT3cfm/8AfklMLW1Vvbbs9v0bJxjAH5r9R+Y5ELWtIfUC
yxuoLcdzZ/kOIH0Hp7fV9J/9J+ifpent4/O/kp6/V9NsfaogRPp+H8r3JKbH2yv7N68Onj0o9+7/
AEWz/SJLP9/27/D7v7Ext/7a9X/0Skkp/9k=

------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/fraimg5p.jpg
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------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/mail.gif

R0lGODdhDgALAKIAAP//////AMbGxoSEhISEAAAAAAAAAAAAACwAAAAADgALAAADNDi6vDUAhChp
KK/YXcgTxRSJ3fAEYBV1ggkB3si2JyF4mG27tnATvZvLRyz6XI2kCcNsOhMAOw==

------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/homeld.jpg
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------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/gif
Content-Transfer-Encoding: base64
Content-Location: http://83.224.70.5/www.cesil.comm/0898/bottpiue.gif
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=

------=_NextPart_000_00A0_01C892A7.5AA1DC50
Content-Type: image/jpeg
Content-Transfer-Encoding: base64
Content-Location: http://www.cesil.com/0898/ficasfon.jpg
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=

------=_NextPart_000_00A0_01C892A7.5AA1DC50--

